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Abstract
We present the case of a 47-year-old male who was 
diagnosed with Visual Snow Syndrome following extensive 
specialist consults and medical testing. With an unknown 
pathogenesis, Visual Snow Syndrome is very difficult to 
treat and there is no one treatment suited for all patients. 
The patient in this case report was successfully treated with 
Amitriptyline based on the hypothesis that Visual Snow 
Syndrome is a form of peripheral neuropathy and pituitary 
fatigue. With nearly 200 documented cases of visual snow 
worldwide [1], this case will add to the possible successful 
treatment options.
he was utilizing a vibrating tool at work. Following 
its use, he noticed disrupted vision which persisted 
for months. His vision was described as continuous 
flashes of black and white which were constant with no 
variation throughout the day. He soon developed severe 
muscle pain, irritable bowel syndrome and lethargy (all 
symptoms of pituitary fatigue), however he had no 
neurological impairments. Multiple ophthalmologists 
and neurologists have performed tests and exams 
including MRI, VERs, Goldman field testing, visual acuity 
and fundoscopy. All results were reported as normal. 
His extensive evaluation demonstrated a functional 
disruption in vision without any structural abnormality. 
Following months of investigations and specialist 
consults, he was subsequently diagnosed with visual 
snow syndrome.
The overall pathophysiology is unknown, however 
there have been some theories postulated which 
include pathology related to the visual cortex, anterior 
to the optic radiations or beyond the lateral geniculate 
nucleus [1]. Visual snow syndrome has also been 
thought to be associated with both post-concussive 
syndrome and migraines, however, patients with no 
history of migraines nor concussions still suffer from 
visual snow syndrome. It has been reported that these 
patients are often trial treated with anti-depressants 
or anti-migraine medications [2], however no single 
treatment has worked for every patient.
The patient presented in this case report was treat-
ed successfully with amitriptyline, based on a hypothe-
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Visual snow syndrome is a very rare disease which 
can be detrimental to patients. It is often described as 
a visual disturbance present in the entire visual field 
with flickering white and black dots, similar to the static 
seen on an analogue television [2]. With the increasing 
awareness of this condition, criteria have been created 
to diagnose this clinical syndrome. Criteria include 
dynamic tiny dots lasting longer than 3 months 
spanning the visual field, symptoms not consistent with 
a typical migraine visual aura, having normal visual 
tests and presence of at least 2 of the following 4 visual 
symptoms; palinopsia, enhanced entopic phenomenon, 
photophobia, nyctalopia [2].
A 47-year-old man with no prior medical history 
was in a motor vehicle accident. He was subsequently 
cleared by hospital doctors and promptly returned to 
work as a building developer. A day following discharge 
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There are 200 documented cases of visual snow 
worldwide [1] and this case will add to the possible 
successful treatment options. There are still many 
unknowns regarding pathophysiology of visual snow 
syndrome. Once this is solidified, further research must 
be done to determine the best treatment options for 
these patients. 
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sis that visual snow syndrome is a form of pituitary fa-
tigue and peripheral neuropathy. Endocrinologists often 
encounter patients with pituitary fatigue, it is described 
as a dysregulation of hormone production from the pi-
tuitary gland which can be caused by trauma, stress or 
severe illness. These patients often suffer from severe 
exhaustion, peripheral nerve pain and irritable bowel 
syndrome. In these patients, the hormone levels are 
adequate, however the circadian circadian rhythm of 
the pituitary hormones is dysregulated. This ultimately 
leads to an imbalance of hormones at the neuromuscu-
lar junction [3].
As the patient presented suffered from symptoms of 
pituitary fatigue, it was hypothesized that an imbalance 
of hormones at the ocular muscle junctions led to 
his visual snow syndrome. Amitriptyline (a tricyclic 
antidepressant), functions by blocking the reuptake of 
serotonin and noradrenaline at the postsynaptic cleft 
[4]. This subsequently leads to an increased level of 
hormones which enables proper sensory function to 
be restored [3]. The patient was prescribed a low dose 
of 25 mgs per day, which is the same dose often given 
to uncontrolled diabetics who present with pituitary 
fatigue.
